Skip to content
Recall Observatory FDA recall evidence

Drug product

EQUALINE aller-ease fexofenadine hydrochloride tablets, 180 mg, 24 HR, packaged as a) 15 count bottle, NDC 41163-571-22, UPC 0 41163 48067 4; b) 70 tablets per bottle, NDC 41163-571-01, UPC 0 41163 49847 1; Made in the Czech Republic, Distributed by: UNFI Providence, RI 02908.

D-0328-2022

July 27, 2021

Class II

Product summary

Firm
Perrigo Company PLC
Event
Event 88384
Status
Terminated
Classification
Class II
Quantity
55,032 units
Official record key
drug-enforcement:D-0328-2022

Official wording

Reason: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Code information: Lot # a)0HE2530 Exp 12/31/2021, 0KE2980 EXP 02/28/2022 b)0FR0461 Exp 2/28/2022

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification